Related Experiment Video
Updated: Jan 31, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
β-Lactamase inhibitor peptides as the new strategies to overcome bacterial resistance
O N Silva1, O L Franco2, W F Porto3
1S-Inova Biotech, Pós-graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil. osmar.silva@catolica.edu.
Abstract:
Bacterial resistance has become a problem of great concern all over the world. Gram-negative bacteria, including the Enterobacteriaceae family and Pseudomonas and Acinetobacter species, are among the leading causes of healthcare-associated infections. The rate of antibiotic resistance among these pathogens has increased dramatically in recent years, reaching a pandemic scale. The most common mechanism of resistance described for Gram-negative bacteria consists of beta-lactamase production. These enzymes hydrolyze beta-lactam antibiotics, which are among the most commonly used antimicrobial agents. As with other antibiotics, reports of bacterial resistance to these agents have increased in recent years. An alternative method for combating beta-lactamasemediated resistance has been the use of small beta-lactamase inhibitors (e.g., clavulanic acid and tazobactam), allowing the resurgence of beta-lactam antibiotics for the treatment of infections caused by beta-lactamase-producing bacteria. However, due to the beta-lactamase group's diversity, some of them present resistance to conventional beta-lactamase inhibitors. Bearing this in mind, in the last two decades, beta- lactamase inhibitor peptides have been developed as alternative adjuvants to strike back against such strains. In this review, we outline the most recent findings related to the design of beta-lactamase inhibitor peptides and their biotechnological potential.
Insights
Bacterial resistance to antibiotics is a global crisis. New beta-lactamase inhibitor peptides offer a promising strategy against resistant Gram-negative bacteria, overcoming limitations of current inhibitors.
Area of Science:
- Microbiology
- Biotechnology
- Drug Discovery
Background:
- Antibiotic resistance in Gram-negative bacteria (e.g., Enterobacteriaceae, Pseudomonas, Acinetobacter) is a major global health threat.
- Beta-lactamase production is a primary mechanism of resistance, hydrolyzing widely used beta-lactam antibiotics.
- Existing beta-lactamase inhibitors are becoming less effective due to diverse beta-lactamase enzymes.
Purpose of the Study:
- To review recent advancements in the design of beta-lactamase inhibitor peptides.
- To explore the biotechnological potential of these novel peptide inhibitors.
- To address the challenge of bacterial resistance to conventional treatments.
Main Methods:
- Literature review focusing on recent findings in beta-lactamase inhibitor peptide design.
- Analysis of studies detailing the development and characterization of these peptides.
- Evaluation of biotechnological applications and potential.
Main Results:
- Emerging beta-lactamase inhibitor peptides show promise in combating resistant Gram-negative bacteria.
- These peptides offer an alternative strategy when conventional inhibitors fail.
- Recent research highlights innovative designs and biotechnological applications.
Conclusions:
- Beta-lactamase inhibitor peptides represent a significant development in antimicrobial strategies.
- Their design and biotechnological potential are crucial for addressing the pandemic of antibiotic resistance.
- Further research is needed to fully realize their therapeutic applications.
More Related Videos
Related Concept Videos
Peptide Bonds
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Bacterial Signaling
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Resistivity

